An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, ...

Ozempic, Wegovy and Mounjaro can reduce risk of heart disease, dementia, and much more, says groundbreaking US study ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

Elon Musk, the CEO of Tesla and SpaceX, has been candid about his struggle with weight loss. The billionaire has openly ...